Related Articles
PD‑L1 expression is associated with advanced non‑small cell lung cancer
A combination of PD‑1/PD‑L1 inhibitors: The prospect of overcoming the weakness of tumor immunotherapy (Review)
Comparative efficacy and safety of first‑line PD‑1/PD‑L1 inhibitors in immunotherapy for non‑small cell lung cancer: <br />A network meta‑analysis
Liquid biopsy for lung cancer immunotherapy (Review)
Expression of immune checkpoint PD‑1 in non‑small cell lung cancer is associated with tumor cell DNA‑dependent protein kinase